Pescovitz MD - Search Results

1

Basiliximab versus antithymocyte globulin for prevention of acute renal allograft rejection.

Sollinger H, Kaplan B, Pescovitz MD, Philosophe B, Roza A, Brayman K, Somberg K. Sollinger H, et al. Among authors: pescovitz md. Transplantation. 2001 Dec 27;72(12):1915-9. doi: 10.1097/00007890-200112270-00008. Transplantation. 2001. PMID: 11773888 Clinical Trial.

2

Differential influence of azathioprine and mycophenolate mofetil on the disposition of basiliximab in renal transplant patients.

Kovarik JM, Pescovitz MD, Sollinger HW, Kaplan B, Legendre C, Salmela K, Book BK, Gerbeau C, Girault D, Somberg K; Simulect Phase IV Sudy group. Kovarik JM, et al. Among authors: pescovitz md. Clin Transplant. 2001 Apr;15(2):123-30. doi: 10.1034/j.1399-0012.2001.150208.x. Clin Transplant. 2001. PMID: 11264639 Clinical Trial.

3

Intravenous mycophenolate mofetil: safety, tolerability, and pharmacokinetics.

Pescovitz MD, Conti D, Dunn J, Gonwa T, Halloran P, Sollinger H, Tomlanovich S, Weinstein S, Inokuchi S, Kiberd B, Kittur D, Merion RM, Norman D, Shoker A, Wilburn R, Nicholls AJ, Arterburn S, Dumont E. Pescovitz MD, et al. Clin Transplant. 2000 Jun;14(3):179-88. doi: 10.1034/j.1399-0012.2000.140301.x. Clin Transplant. 2000. PMID: 10831074 Free article. Clinical Trial.

4

Two-hour post-dose cyclosporine level is a better predictor than trough level of acute rejection of renal allografts.

Pescovitz MD, Barbeito R; Simulect US01 Study Group. Pescovitz MD, et al. Clin Transplant. 2002 Oct;16(5):378-82. doi: 10.1034/j.1399-0012.2002.02036.x. Clin Transplant. 2002. PMID: 12225436 Clinical Trial.

5

Cytomegalovirus infections after treatment with daclizumab, an anti IL-2 receptor antibody, for prevention of renal allograft rejection. Roche Study Group.

Hengster P, Pescovitz MD, Hyatt D, Margreiter R. Hengster P, et al. Among authors: pescovitz md. Transplantation. 1999 Jul 27;68(2):310-3. doi: 10.1097/00007890-199907270-00028. Transplantation. 1999. PMID: 10440409 Clinical Trial.

6

Results of 3-year phase III clinical trials with daclizumab prophylaxis for prevention of acute rejection after renal transplantation.

Bumgardner GL, Hardie I, Johnson RW, Lin A, Nashan B, Pescovitz MD, Ramos E, Vincenti F; Phase III Daclizumab Study Group. Bumgardner GL, et al. Among authors: pescovitz md. Transplantation. 2001 Sep 15;72(5):839-45. doi: 10.1097/00007890-200109150-00017. Transplantation. 2001. PMID: 11571447 Clinical Trial.

7

Thromboembolic complications in renal allograft recipients. A report from the prospective randomized study of cyclosporine versus azathioprine-antilymphocyte globulin.

Gruber SA, Pescovitz MD, Simmons RL, Najarian JS, Ascher NL, Payne WD, Sutherland DE, Fryd DS. Gruber SA, et al. Among authors: pescovitz md. Transplantation. 1987 Dec;44(6):775-8. doi: 10.1097/00007890-198712000-00010. Transplantation. 1987. PMID: 3321586 Clinical Trial.

8

Sirolimus reduces the incidence of acute rejection episodes despite lower cyclosporine doses in caucasian recipients of mismatched primary renal allografts: a phase II trial. Rapamune Study Group.

Kahan BD, Julian BA, Pescovitz MD, Vanrenterghem Y, Neylan J. Kahan BD, et al. Among authors: pescovitz md. Transplantation. 1999 Nov 27;68(10):1526-32. doi: 10.1097/00007890-199911270-00016. Transplantation. 1999. PMID: 10589950 Clinical Trial.

9

The safety and tolerability of cyclosporine emulsion versus cyclosporine in a randomized, double-blind comparison in primary renal allograft recipients. The Neoral Study Group.

Barone G, Bunke CM, Choc MG Jr, Hricik DE, Jin JH, Klein JB, Marsh CL, Min DI, Pescovitz MD, Pollak R, Pruett TL, Stinson JB, Thompson JS, Vasquez E, Waid T, Wombolt DG, Wong RL. Barone G, et al. Among authors: pescovitz md. Transplantation. 1996 Mar 27;61(6):968-70. doi: 10.1097/00007890-199603270-00021. Transplantation. 1996. PMID: 8623168 Clinical Trial.

10

Randomized controlled trial of FTY720 versus MMF in de novo renal transplantation.

Tedesco-Silva H, Pescovitz MD, Cibrik D, Rees MA, Mulgaonkar S, Kahan BD, Gugliuzza KK, Rajagopalan PR, Esmeraldo Rde M, Lord H, Salvadori M, Slade JM; FTY720 Study Group. Tedesco-Silva H, et al. Among authors: pescovitz md. Transplantation. 2006 Dec 27;82(12):1689-97. doi: 10.1097/01.tp.0000251718.95622.b3. Transplantation. 2006. PMID: 17198261 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

211 results

Search Page